CTOs on the Move

National Association of Community Health Centers

www.nachc.com

 
National Association of Community Health Centers, Inc. is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nachc.com
  • 2001 L St NW Frnt 2
    Washington, DC USA 20036
  • Phone: 202.296.1721

Executives

Name Title Contact Details

Similar Companies

American Academy of CME

American Academy of CME is a Skillman, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Senior Home Care

Senior Home Care offers the full range of covered Medicare Certified Home Health Services throughout Florida. For more information about Senior Home Care, please contact us at: Senior Home Care, Inc.

Restore

Restore Hyper Wellness is the award-winning creator of an innovative new category of care—Hyper Wellness®. Restore delivers expert guidance and an extensive array of cutting-edge health modalities, such as IV drips and cryotherapy, integrated under one roof. These modalities help you feel your best, so you can do more of what you love. With 120+ locations across 34+ states and a fast-growing national retail footprint, Restore makes proactive health more accessible than ever.

Solvay Pharmaceuticals Inc

Solvay Pharmaceuticals Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.